Your browser doesn't support javascript.
loading
A therapeutic DNA vaccine and gemcitabine act synergistically to eradicate HPV-associated tumors in a preclinical model.
Ramos da Silva, Jamile; Ramos Moreno, Ana Carolina; Silva Sales, Natiely; de Oliveira Silva, Mariângela; Aps, Luana R M M; Porchia, Bruna F M M; Bitencourt Rodrigues, Karine; Cestari Moreno, Natália; Venceslau-Carvalho, Aléxia Adrianne; Menck, Carlos Frederico M; de Oliveira Diniz, Mariana; de Souza Ferreira, Luís Carlos.
Afiliação
  • Ramos da Silva J; Vaccine Development Laboratory, Department of Microbiology, Biomedical Sciences Institute, University of São Paulo, São Paulo, Brazil.
  • Ramos Moreno AC; Vaccine Development Laboratory, Department of Microbiology, Biomedical Sciences Institute, University of São Paulo, São Paulo, Brazil.
  • Silva Sales N; Vaccine Development Laboratory, Department of Microbiology, Biomedical Sciences Institute, University of São Paulo, São Paulo, Brazil.
  • de Oliveira Silva M; Vaccine Development Laboratory, Department of Microbiology, Biomedical Sciences Institute, University of São Paulo, São Paulo, Brazil.
  • Aps LRMM; Vaccine Development Laboratory, Department of Microbiology, Biomedical Sciences Institute, University of São Paulo, São Paulo, Brazil.
  • Porchia BFMM; Vaccine Development Laboratory, Department of Microbiology, Biomedical Sciences Institute, University of São Paulo, São Paulo, Brazil.
  • Bitencourt Rodrigues K; Laboratory of Tumor Immunology, Department of Immunology, Biomedical Sciences Institute, University of São Paulo, São Paulo, Brazil.
  • Cestari Moreno N; Vaccine Development Laboratory, Department of Microbiology, Biomedical Sciences Institute, University of São Paulo, São Paulo, Brazil.
  • Venceslau-Carvalho AA; DNA Repair Laboratory, Department of Microbiology, Biomedical Sciences Institute, University of São Paulo, São Paulo, Brazil.
  • Menck CFM; Mitochondrial Genetics Lab. Department of Biochemistry, Institute of Chemistry, University of São Paulo, São Paulo, Brazil.
  • de Oliveira Diniz M; Vaccine Development Laboratory, Department of Microbiology, Biomedical Sciences Institute, University of São Paulo, São Paulo, Brazil.
  • de Souza Ferreira LC; DNA Repair Laboratory, Department of Microbiology, Biomedical Sciences Institute, University of São Paulo, São Paulo, Brazil.
Oncoimmunology ; 10(1): 1949896, 2021.
Article em En | MEDLINE | ID: mdl-34367730
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Colo do Útero / Vacinas de DNA / Infecções por Papillomavirus / Alphapapillomavirus / Vacinas contra Papillomavirus Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals / Female / Humans Idioma: En Revista: Oncoimmunology Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Brasil País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Colo do Útero / Vacinas de DNA / Infecções por Papillomavirus / Alphapapillomavirus / Vacinas contra Papillomavirus Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals / Female / Humans Idioma: En Revista: Oncoimmunology Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Brasil País de publicação: Estados Unidos